US$ 25.37
tirzepatide pdufa Quarterly Drug Pipeline: April 2025 - Prime Therapeutics GLP-2 Tirzepatide · Disguised Alpha
Description
Food and Drug Administration approved tirzepatide (Zepbound) injection for chronic weight management in adults with a BMI of 30 or with a BMI of 27 or greater with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) this November

Encouragingly, in the subgroup of persistent, GLP-1 naive patients, a mean 12.9% weight reduction compared to baseline values was observed, highlighting the drug's effectiveness

J.McKenzieJ

That results in an extremely dry vaginal region
